Phosphodiesterase 1b (Pde1b) governs development and immune responses of myeloid and lymphoid cells through regulation of cyclic nucleotide-dependent protein kinases
Ontology highlight
ABSTRACT: Elevated cAMP and cGMP levels suppress immune functions in antigen presenting cells, while phosphodiesterases enzymatically degrade these cyclic nucleotides to regulate their intracellular concentrations. This study demonstrates that selective expression of the calcium/calmodulin-dependent phosphodiesterase 1b (Pde1b) in specific dendritic cell (DC) and macrophage subsets is essential for promoting inflammation and adaptive immunity. Utilizing single-cell RNA sequencing and multiparameter flow cytometry, Pde1b deficiency was found to alter gene expression and protein functions involved in development or immune effector activity in DC, macrophages, granulocytes, B cells, NK cells and memory T cells. In vivo pathogen challenge studies in Pde1b-deficient mice resulted in markedly attenuated pro-inflammatory and antigen-specific T cell responses. Notably, Pde1b-deficient DC and macrophages exhibited elevated cyclic nucleotides levels and enhanced cyclic nucleotide-dependent PKA and PKG activity. These findings establish Pde1b as a pivotal regulator of cyclic nucleotide signaling that shapes immune development and responses.
ORGANISM(S): Mus musculus
PROVIDER: GSE297611 | GEO | 2026/09/11
REPOSITORIES: GEO
ACCESS DATA